203 related articles for article (PubMed ID: 32360274)
21. Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns: a clinicopathologic study of 183 patients.
Volante M; Landolfi S; Chiusa L; Palestini N; Motta M; Codegone A; Torchio B; Papotti MG
Cancer; 2004 Mar; 100(5):950-7. PubMed ID: 14983490
[TBL] [Abstract][Full Text] [Related]
22. Cytologic features of aggressive variants of follicular-derived thyroid carcinoma.
Rossi ED; Faquin WC; Pantanowitz L
Cancer Cytopathol; 2019 Jul; 127(7):432-446. PubMed ID: 31150164
[TBL] [Abstract][Full Text] [Related]
23. Genetic alterations involved in the transition from well-differentiated to poorly differentiated and anaplastic thyroid carcinomas.
Nikiforov YE
Endocr Pathol; 2004; 15(4):319-27. PubMed ID: 15681856
[TBL] [Abstract][Full Text] [Related]
24. Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers.
Landa I; Ibrahimpasic T; Boucai L; Sinha R; Knauf JA; Shah RH; Dogan S; Ricarte-Filho JC; Krishnamoorthy GP; Xu B; Schultz N; Berger MF; Sander C; Taylor BS; Ghossein R; Ganly I; Fagin JA
J Clin Invest; 2016 Mar; 126(3):1052-66. PubMed ID: 26878173
[TBL] [Abstract][Full Text] [Related]
25. Prognostic classification of thyroid follicular cell tumors using Ki-67 labeling index: risk stratification of thyroid follicular cell carcinomas.
Kakudo K; Wakasa T; Ohta Y; Yane K; Ito Y; Yamashita H
Endocr J; 2015; 62(1):1-12. PubMed ID: 25195708
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathological Characteristics and Prognosis of Poorly Differentiated Thyroid Carcinoma Diagnosed According to the Turin Criteria.
Huang J; Sun W; Zhang Q; Wang Z; Dong W; Zhang D; Lv C; Shao L; Zhang P; Zhang H
Endocr Pract; 2021 May; 27(5):401-407. PubMed ID: 33934750
[TBL] [Abstract][Full Text] [Related]
27. Cribriform-morular variant of papillary thyroid carcinoma displaying poorly differentiated features.
Nakazawa T; Celestino R; Machado JC; Cameselle-Teijeiro JM; Vinagre J; Eloy C; Benserai F; Lameche S; Soares P; Sobrinho-Simões M
Int J Surg Pathol; 2013 Aug; 21(4):379-89. PubMed ID: 23349472
[TBL] [Abstract][Full Text] [Related]
28. Poorly differentiated thyroid carcinoma: a cytologic-histologic review.
Bongiovanni M; Sadow PM; Faquin WC
Adv Anat Pathol; 2009 Sep; 16(5):283-9. PubMed ID: 19700938
[TBL] [Abstract][Full Text] [Related]
29. Prognostic Significance of Extent of Invasion in Poorly Differentiated Thyroid Carcinoma.
Wong KS; Lorch JH; Alexander EK; Marqusee E; Cho NL; Nehs MA; Doherty GM; Barletta JA
Thyroid; 2019 Sep; 29(9):1255-1261. PubMed ID: 31397224
[No Abstract] [Full Text] [Related]
30. The story of poorly differentiated thyroid carcinoma: From Langhans' description to the Turin proposal via Juan Rosai.
Volante M; Bussolati G; Papotti M
Semin Diagn Pathol; 2016 Sep; 33(5):277-83. PubMed ID: 27344303
[TBL] [Abstract][Full Text] [Related]
31. Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP): An Update.
Xu B; Ghossein RA
Head Neck Pathol; 2020 Jun; 14(2):303-310. PubMed ID: 32124418
[TBL] [Abstract][Full Text] [Related]
32. Poorly differentiated carcinoma of the thyroid. A clinicopathologic entity for a high-risk group of papillary and follicular carcinomas.
Sakamoto A; Kasai N; Sugano H
Cancer; 1983 Nov; 52(10):1849-55. PubMed ID: 6313176
[TBL] [Abstract][Full Text] [Related]
33. The evolving concept of aggressive histological variants of differentiated thyroid cancer.
Hernandez-Prera JC
Semin Diagn Pathol; 2020 Sep; 37(5):228-233. PubMed ID: 32241577
[TBL] [Abstract][Full Text] [Related]
34. Poorly Differentiated Carcinoma of the Thyroid Gland: Current Status and Future Prospects.
Ibrahimpasic T; Ghossein R; Shah JP; Ganly I
Thyroid; 2019 Mar; 29(3):311-321. PubMed ID: 30747050
[TBL] [Abstract][Full Text] [Related]
35. Histopathology and immunohistochemistry as prognostic factors for poorly differentiated thyroid cancer in a series of Polish patients.
Walczyk A; Kopczyński J; Gąsior-Perczak D; Pałyga I; Kowalik A; Chrapek M; Hejnold M; Góźdź S; Kowalska A
PLoS One; 2020; 15(2):e0229264. PubMed ID: 32092093
[TBL] [Abstract][Full Text] [Related]
36. Advances in Thyroid Pathology: High Grade Follicular Cell-derived Thyroid Carcinoma and Anaplastic Thyroid Carcinoma.
Xu B; Ghossein RA
Adv Anat Pathol; 2023 Jan; 30(1):3-10. PubMed ID: 36306188
[TBL] [Abstract][Full Text] [Related]
37. Atypical Features Resembling Poorly Differentiated Thyroid Carcinoma Presenting Entirely within a Follicular Adenoma.
Ching D; Leslie C
Case Rep Pathol; 2018; 2018():7290343. PubMed ID: 30112239
[TBL] [Abstract][Full Text] [Related]
38. Primary high-grade non-anaplastic thyroid carcinoma: a retrospective study of 364 cases.
Xu B; David J; Dogan S; Landa I; Katabi N; Saliba M; Khimraj A; Sherman EJ; Tuttle RM; Tallini G; Ganly I; Fagin JA; Ghossein RA
Histopathology; 2022 Jan; 80(2):322-337. PubMed ID: 34449926
[TBL] [Abstract][Full Text] [Related]
39. Histopathologic characterization of radioactive iodine-refractory fluorodeoxyglucose-positron emission tomography-positive thyroid carcinoma.
Rivera M; Ghossein RA; Schoder H; Gomez D; Larson SM; Tuttle RM
Cancer; 2008 Jul; 113(1):48-56. PubMed ID: 18484584
[TBL] [Abstract][Full Text] [Related]
40. Comprehensive DNA Methylation Profiling Identifies Novel Diagnostic Biomarkers for Thyroid Cancer.
Park JL; Jeon S; Seo EH; Bae DH; Jeong YM; Kim Y; Bae JS; Kim SK; Jung CK; Kim YS
Thyroid; 2020 Feb; 30(2):192-203. PubMed ID: 31797753
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
